• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Lantheus Holdings, Inc.

< Previous 1 2 Next >
Lantheus to Present at the Jefferies London Healthcare Conference
November 08, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Reports Third Quarter 2023 Financial Results
November 02, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus to Host Third Quarter 2023 Earnings Conference Call and Webcast on November 2, 2023, at 8:00 a.m. Eastern Time
October 19, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Association of Nuclear Medicine (EANM) Annual Meeting
September 01, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus to Present at the Wells Fargo Healthcare Conference
August 31, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare Royalty
August 03, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Reports Second Quarter 2023 Financial Results
August 03, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus to Host Second Quarter 2023 Earnings Conference Call and Webcast on August 3, 2023, at 8:00 a.m. Eastern Time
July 20, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Announces Presentations Featuring PYLARIFY AI™ at the 2023 Society for Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
June 12, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus to Present at the Jefferies Healthcare Conference
June 01, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Announces Payment to Contingent Value Rights (CVR) Holders of $99.7 million or $1.15 per CVR
May 23, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Reports First Quarter 2023 Financial Results
May 04, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus to Host First Quarter 2023 Earnings Conference Call and Webcast on May 4, 2023, at 8:00 a.m. Eastern Time
April 20, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Announces Two Key Executive Promotions
March 17, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels
February 16, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus to Host Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast on February 23, 2023, at 8:00 a.m. Eastern Time
February 09, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus to Present Piflufolastat F 18 Data at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
February 08, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Announces Acquisition of Cerveau Technologies, Inc., Expanding Imaging Pipeline into Alzheimer’s Disease
February 06, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference
January 04, 2023
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Announces Closing of Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 with POINT Biopharma
December 20, 2022
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Grants Rights for the Use of its Microbubbles to SonoThera for its Ultrasound-Guided Nonviral Gene Therapy Platform
December 12, 2022
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027
December 06, 2022
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior Notes due 2027
December 05, 2022
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Announces Appointment of Amanda Morgan as Senior Vice President, Commercial
November 29, 2022
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Announces the Approval of DEFINITY® (Perflutren Lipid Microsphere) by China’s NMPA
November 28, 2022
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003
November 14, 2022
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH PNT
Lantheus to Present at the Jefferies London Healthcare Conference
November 09, 2022
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus Reports Third Quarter 2022 Financial Results
November 03, 2022
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
Lantheus to Host Third Quarter 2022 Earnings Conference Call and Webcast on November 3, 2022, at 8:00 a.m. Eastern Time
October 20, 2022
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap